International Journal of Drug Discovery and Pharmacology

Aims & Scope

International Journal of Drug Discovery and Pharmacology (IJDDP) is a gold open access, peer-reviewed journal giving leading international coverage across all disciplines of drug discovery and experimental pharmacology. IJDDP is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to academics, clinicians, pharmacists, allied healthcare professionals and the public worldwide. In addition, IJDDP publishes rigorously peer-reviewed research including original research, authoritative reviews, systematic reviews, minireviews, commentary and letters to the editor, related to the discovery of new therapeutic targets, new drugs, or new therapeutic modalities. IJDDP also encourages submissions describing innovations in data science and clinical trial designs pertaining to broad disease domains. IJDDP welcomes findings derived from the application of structural biology, biochemistry, biophysics, physiology, pathology, genetics, molecular biology, systems biology and data science to address pharmacological problems that provide mechanistic insights and innovative approaches important for the fields of drug discovery. The termed drugs comprise a wide variety of agents, including small molecules and biologics.

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Subject Classification